Atomera (ATOM) CTO uses 10b5-1 plan to exercise options and sell shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Atomera Inc Chief Technology Officer Robert J. Mears reported a series of option exercises and open-market share sales in Atomera common stock. On June 8–9, 2026, he exercised options to acquire a total of 48,115 shares at exercise prices of $7.01 and $7.65 per share, then sold 55,168 shares in multiple open-market transactions at prices between $8.20 and $8.75 per share. The filing notes that both the option exercises and the sales were carried out under a pre-arranged Rule 10b5-1 trading plan, indicating these trades were scheduled in advance rather than timed discretionarily.
Positive
- None.
Negative
- None.
Insights
Routine option exercises paired with pre-planned sales under a 10b5-1 plan.
CTO Robert J. Mears exercised stock options to acquire 48,115 Atomera shares at exercise prices of $7.01 and $7.65, then sold 55,168 shares in open-market trades priced between $8.20 and $8.75.
The filing’s footnotes state that both the option exercises and the sales were executed pursuant to a Rule 10b5-1 trading plan. Such plans are established in advance, so the timing of these trades is typically viewed as routine rather than a reaction to new information.
The transactions result in a modest net reduction in Mears’ shareholdings but are relatively small compared with the six-figure share balances shown in the filing. With no remaining derivative positions listed, this appears to be an exercise-and-sell pattern from previously reported options.
Insider Trade Summary 10b5-1
Net Seller: 55,168 shares ($464,478)
Net Sell
18 txns
Insider
Mears Robert J
Role
Chief Technology Officer
Sold
55,168 shs ($464K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Incentive Stock Option (right to buy) | 10,000 | $0.00 | -- |
| Exercise | Non-Qualified Stock Option (right to buy) | 10,000 | $0.00 | -- |
| Exercise | Common Stock | 10,000 | $7.01 | $70K |
| Sale | Common Stock | 10,000 | $8.75 | $88K |
| Exercise | Common Stock | 10,000 | $7.01 | $70K |
| Sale | Common Stock | 8,012 | $8.75 | $70K |
| Exercise | Incentive Stock Option (right to buy) | 10,000 | $0.00 | -- |
| Exercise | Incentive Stock Option (right to buy) | 8,115 | $0.00 | -- |
| Exercise | Non-Qualified Stock Option (right to buy) | 10,000 | $0.00 | -- |
| Exercise | Common Stock | 10,000 | $7.01 | $70K |
| Sale | Common Stock | 10,000 | $8.20 | $82K |
| Exercise | Common Stock | 10,000 | $7.01 | $70K |
| Sale | Common Stock | 8,863 | $8.20 | $73K |
| Exercise | Common Stock | 8,115 | $7.65 | $62K |
| Sale | Common Stock | 7,313 | $8.50 | $62K |
| Sale | Common Stock | 9,980 | $8.20 | $82K |
| Sale | Common Stock | 1,000 | $8.20 | $8K |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Incentive Stock Option (right to buy) — 18,465 shares (Direct, null);
Non-Qualified Stock Option (right to buy) — 32,378 shares (Direct, null);
Common Stock — 278,909 shares (Direct, null);
Common Stock — 2,666 shares (Indirect, by Spouse)
Footnotes (1)
- The option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and exercised from a previously reported total. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Key Figures
Shares sold: 55,168 shares
Shares acquired via option exercise: 48,115 shares
Sale prices: $8.20–$8.75 per share
+3 more
6 metrics
Shares sold
55,168 shares
Total open-market sales reported in Form 4
Shares acquired via option exercise
48,115 shares
Total shares from option exercises reported
Sale prices
$8.20–$8.75 per share
Range of common stock sale prices on June 8–9, 2026
Option exercise prices
$7.01 and $7.65 per share
Exercise prices for non-qualified and incentive stock options
Direct holdings after one sale
270,897 shares
Total shares following a June 9, 2026 sale line
Indirect holdings by spouse
2,666 shares
Common stock held indirectly, reported as by spouse
Key Terms
Rule 10b5-1 trading plan, Non-Qualified Stock Option, Incentive Stock Option, open-market sale, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"The option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Non-Qualified Stock Option financial
"Non-Qualified Stock Option (right to buy)"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
Incentive Stock Option financial
"Incentive Stock Option (right to buy)"
An incentive stock option is a type of employee benefit that gives a worker the right to buy company shares at a fixed price, with special tax advantages if the employee holds the shares for a required period. Think of it as a coupon to buy future shares at today’s price that can result in lower tax on the gain. Investors care because ISOs can dilute share count, align staff incentives with the stock price, and affect company compensation costs and the timing of potential share sales.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
FAQ
What insider transactions did Atomera (ATOM) CTO Robert Mears report?
Robert Mears reported exercising stock options for 48,115 Atomera shares and selling 55,168 shares in open-market trades. The sales occurred at prices between $8.20 and $8.75 per share over June 8–9, 2026, according to the Form 4 filing.
What stock options did Atomera (ATOM) CTO Robert Mears exercise in this filing?
Mears exercised options covering 48,115 Atomera common shares. The exercises included non-qualified and incentive stock options with exercise prices of $7.01 and $7.65 per share, originally granted in 2016–2017, according to the option details in the Form 4.
What does a Rule 10b5-1 trading plan mean for Atomera (ATOM) insider trades?
A Rule 10b5-1 trading plan allows insiders to pre-schedule trades when they are not aware of material nonpublic information. For Atomera, the filing notes Mears’ exercises and sales followed such a plan, suggesting routine portfolio management rather than opportunistic timing.